Skip to main content
See every side of every news story
Published • loading... • Updated

BioSyent Declares Fourth Quarter 2026 Dividend

The quarterly payout matches the previous quarter and remains an eligible dividend for Canadian tax purposes, the company said.

  • On Tuesday, BioSyent Inc. President and CEO René Goehrum announced in Mississauga, Ontario, that the Board of Directors declared a quarterly dividend of $0.055 per common share, payable December 15, 2026.
  • BioSyent's recent performance includes $7.8 million in sales from the Oral Health segment during Q3 2026, following the March 1, 2026 acquisition of Oral Science Inc.
  • Strengthening its financial position, the company repaid $2 million in acquisition debt on October 1, 2026, while deploying $1.7 million in share buybacks and $0.6 million in dividends during Q3.
  • Goehrum noted the firm maintains a strong cash position to "hedge against future risks," supported by $6.0 million in combined operating cash flows during the third quarter.
  • Investment continues into 2027, with the company preparing to launch the pharmaceutical product Thyconvi in Canada during the first quarter of 2027.
Insights by Ground AI

9 Articles

Globe NewswireGlobe Newswire
+3 Reposted by 3 other sources
Center

BioSyent Declares Fourth Quarter 2026 Dividend

MISSISSAUGA, Ontario, Nov. 17, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources lean Left
63% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal